GB0400329D0 - Novel processes - Google Patents

Novel processes

Info

Publication number
GB0400329D0
GB0400329D0 GBGB0400329.9A GB0400329A GB0400329D0 GB 0400329 D0 GB0400329 D0 GB 0400329D0 GB 0400329 A GB0400329 A GB 0400329A GB 0400329 D0 GB0400329 D0 GB 0400329D0
Authority
GB
United Kingdom
Prior art keywords
novel processes
novel
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0400329.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0400329.9A priority Critical patent/GB0400329D0/en
Publication of GB0400329D0 publication Critical patent/GB0400329D0/en
Priority to PCT/GB2005/000021 priority patent/WO2005066173A2/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
GBGB0400329.9A 2004-01-08 2004-01-08 Novel processes Ceased GB0400329D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0400329.9A GB0400329D0 (en) 2004-01-08 2004-01-08 Novel processes
PCT/GB2005/000021 WO2005066173A2 (en) 2004-01-08 2005-01-07 Processes for the preparation of substituted azetidinone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0400329.9A GB0400329D0 (en) 2004-01-08 2004-01-08 Novel processes

Publications (1)

Publication Number Publication Date
GB0400329D0 true GB0400329D0 (en) 2004-02-11

Family

ID=31503577

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0400329.9A Ceased GB0400329D0 (en) 2004-01-08 2004-01-08 Novel processes

Country Status (2)

Country Link
GB (1) GB0400329D0 (en)
WO (1) WO2005066173A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017060418A1 (en) * 2015-10-07 2017-04-13 Neurovive Pharmaceutical Ab Protected carboxylic acid-based metabolites for the treatment of mitochondria-related diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996034869A1 (en) * 1995-05-03 1996-11-07 Smithkline Beecham Plc Esters of carbapenems
SK53696A3 (en) * 1993-10-29 1996-10-02 Smithkline Beecham Plc Carbapenem derivatives, their preparation, pharmaceutical compositions containing them and their use

Also Published As

Publication number Publication date
WO2005066173A3 (en) 2008-12-31
WO2005066173A2 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
ZA200609595B (en) Novel CIS-Imidazolines
IL179730A0 (en) Novel cis-imidazolines
TWI372750B (en) Novel hydroxy-6-heteroarylphenanthridines
ZA200610303B (en) Novel cis-imidazolines
GB0414026D0 (en) Novel uses
ZA200606635B (en) Novel isoamido-substituted hydroxy-6-phenylphenanthridines
GB0400382D0 (en) Novel processes
GB0400329D0 (en) Novel processes
GB0408865D0 (en) Novel benzoxazocines
GB0400405D0 (en) Novel processes
GB0408862D0 (en) Novel benzoxazocines
GB0505847D0 (en) Novel benzoxazocines
ZA200608482B (en) Novel tetrahydropyridothiophenes
GB0408863D0 (en) Novel benzoxazocines
GB0422684D0 (en) Novel uses
GB0420274D0 (en) Novel uses
GB0420312D0 (en) Novel uses
GB0420310D0 (en) Novel uses
GB0420304D0 (en) Novel uses
GB0420302D0 (en) Novel uses
GB0423750D0 (en) Novel uses
GB0420301D0 (en) Novel uses
GB0422616D0 (en) Novel uses
GB0422683D0 (en) Novel uses
GB0422681D0 (en) Novel uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)